We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Michele Trott, PhD

Michele Trott, PhD profile page


Michele Trott (nee Wilson) is a New Zealand-based science writer who pursues freelance writing projects alongside her in-house role as a scientific content writer at Izon Science. After completing her PhD (Endocrinology) at Lincoln University (NZ), Michele began pursuing her science writing career with Technology Networks in the UK. There, she spent 12 months covering a maternity leave role as a science editor, and managed the cell science, biopharma and diagnostics communities. Upon her arrival back in NZ, Michele established “Choice Science Writing” and became a full-time freelance science writer, working with life science marketing agencies, biotech companies – and of course, Technology Networks – to produce engaging articles and blog posts. In April 2021, she took up the opportunity to join the team at Izon Science, a company that enables the precise separation and analysis of extracellular vesicles and other nanoparticles.


Got a Question for Michele Trott, PhD?


Get in touch using the contact form linked here and we’ll get back to you shortly.



Published Content
Total: 111
News

A Dynamic Protein Atlas of Human Cell Division

A new 4D computational model which integrates CRISPR, confocal microscopy, and machine learning allows researchers to study the dynamics of specific proteins which drive mitosis. The model is a framework which can be adapted to study other cellular functions.
News

A Dynamic Protein Atlas of Human Cell Division

A new 4D computational model which integrates CRISPR, confocal microscopy, and machine learning allows researchers to study the dynamics of specific proteins which drive mitosis. The model is a framework which can be adapted to study other cellular functions.
Raising Awareness of Sepsis: 8 Milestones From This Decade content piece image
Listicle

Raising Awareness of Sepsis: 8 Milestones From This Decade

'Think Sepsis, Save Lives' is more than just a tidy catchphrase. Here are 8 milestones in raising sepsis awareness from the past decade, according to Dr. Konrad Reinhart, Chair of the Global Sepsis Alliance.
Raising Awareness of Sepsis: 8 Milestones From This Decade content piece image
Listicle

Raising Awareness of Sepsis: 8 Milestones From This Decade

'Think Sepsis, Save Lives' is more than just a tidy catchphrase. Here are 8 milestones in raising sepsis awareness from the past decade, according to Dr. Konrad Reinhart, Chair of the Global Sepsis Alliance.
Tapping Into Diagnostics to Harness the Microbiome content piece image
Infographic

Tapping Into Diagnostics to Harness the Microbiome

The extent to which resident microbes can affect our health is slowly being realized, and our current understanding may be just the tip of the iceberg. Download this infographic to learn how knowledge of the microbiome can be used to aid medical decision-making, as well as current trends, goals, techniques and challenges of the field.
Monitoring Pulmonary Exacerbation in Cystic Fibrosis: The Hunt for Urine-based Biomarkers Begins content piece image
Industry Insight

Monitoring Pulmonary Exacerbation in Cystic Fibrosis: The Hunt for Urine-based Biomarkers Begins

A clinical trial has been launched to identify urine-based biomarkers which indicate lung flare-ups in cystic fibrosis. Researchers believe point-of-care monitoring will help people get treatment faster, improve patient outcomes and reduce healthcare costs.
News

What Does Underwear Choice Have to do with Sperm Count?

This cross-sectional study addressed the age-old fertility question: how does underwear choice affect men's swimmers?
Why is China Becoming a Microfluidics Manufacturing Superpower? content piece image
Industry Insight

Why is China Becoming a Microfluidics Manufacturing Superpower?

Many Chinese microfluidics companies are emerging and expanding, and it could be game-changing for the industry. We spoke with Yole Développement analyst, Sébastien Clerc, to learn more.
Injectable Discogenic Cell Therapy Developed to Alleviate Back Pain content piece image
Industry Insight

Injectable Discogenic Cell Therapy Developed to Alleviate Back Pain

Degenerative disc diseases are debilitating, and treatment options are lacking. Three leaders from Discgenics explain how they are harnessing the restorative potential of cells native to the intervertebral disc to alleviate lower back pain.
Industry Insight

A Move Towards Precise Management of Bacterial Infections

Following the recent FDA approval of a procalcitonin assay, we spoke with a representative from Fujirebio Diagnostics, Inc. to learn how measuring this important biomarker will improve the healthcare landscape.
Advertisement